Table 2 Relationship between TFF1 expression and clinicopathological characteristics of BC patients.

From: Identification of a super enhancer associated gene signature for the prognosis prediction and regulatory mechanism exploration in breast cancer

Variables

TFF1

p-value

Positive (n = 36)

Negative (n = 97)

aN

%

N

%

Age, years

0.212

 33–51

24

66.7

53

54.6

 

 52–83

12

33.3

44

45.4

 

bN status

0.521

 Negative

23

63.9

56

57.7

 

 Positive

13

36.1

41

42.3

 

cT status

0.469

 T1

14

38.9

42

43.3

 

 T2

21

58.3

48

49.5

 

 T3–4

1

2.8

7

7.2

 

Subtype

0.163

 Luminal

24

66.7

50

51.5

 

 HER2 + 

7

19.4

35

36.1

 

 TNBC

5

13.9

12

12.4

 

Ki-67

0.283

 < 14%

8

22.2

14

14.4

 

 ≥ 14%

28

77.8

83

85.6

 
  1. BC, breast cancer; aN, number; %, percentage; bN, lymph node; cT, tumor size; HER2+, human epidermal growth factor receptor 2-positive; TNBC, triple-negative breast cancer.
Back to article page